Outcomes with Autologous Stem Cell Transplant vs. Non-transplant Therapy in Patients 70 Years and Older with Multiple Myeloma

We evaluated 79 patients with multiple myeloma (MM) ≥ 70 years referred to our blood and marrow transplant clinic, within 1 year of diagnosis from 2010–19, for consideration of autologous stem cell transplant (ASCT). Thirty-eight (48%) of 79 patients underwent ASCT. ASCT was not pursued in 41 (52%)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Lemieux, Christopher, Muffly, Lori S., Rezvani, Andrew, Lowsky, Robert, Iberri, David J., Craig, Juliana K., Frank, Matthew J., Johnston, Laura J., Liedtke, Michaela, Negrin, Robert, Weng, Wen-Kai, Meyer, Everett, Shizuru, Judith, Shiraz, Parveen, Arai, Sally, Miklos, David B., Sidana, Surbhi
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019397/
https://ncbi.nlm.nih.gov/pubmed/32782351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-01026-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars